Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
derris scandens extract is a botanical drug product derived from the stems of the woody vine *Derris scandens* Benth, a plant native to Southeast Asia and widely used in Thai traditional medicine. Developed by Mahidol University's Faculty of Medicine at Siriraj Hospital, the extract is primarily indicated for the treatment of knee osteoarthritis. It exerts its therapeutic effects through anti-inflammatory activity, likely involving the inhibition of cyclooxygenase enzymes and other inflammatory mediators. Clinical studies, including a Phase 3 trial, have demonstrated that the extract is efficacious and safe, showing comparable results to the non-steroidal anti-inflammatory drug naproxen in reducing pain and improving physical function in patients with primary knee osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on derris scandens extract.